Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 39Terminated 5Active not recruiting 3Unknown 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 232INDUSTRY 59NIH 5NETWORK 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 18Prostatic Neoplasms 15Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Multiple Myeloma 10Melanoma 9Pancreatic Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Leukemia, Myeloid, Acute 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lung Neoplasms 5Hodgkin Disease 5Sarcoma 4Ovarian Neoplasms 4Osteosarcoma 4Hematologic Neoplasms 4Brain Neoplasms 4Teratoma 3Smoldering Multiple Myeloma 3Small Cell Lung Carcinoma 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Neoplasm Metastasis 3Malignant Solid Neoplasm 3HIV Infections 3Fallopian Tube Neoplasms 3Colonic Neoplasms 3

Interventions

fluciclovine F-18 1Re-Irradiation 1Magnetic Resonance Spectroscopy 1Lomustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Glioblastoma × Clear all
NCT06319027 2026-05-15

GABLE

Eastern Cooperative Oncology Group

Phase 2 Recruiting
100 enrolled
CNS

Glioblastoma

NCT05904119 2026-02-17

LEGATO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
411 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡